A randomized Phase II clinical trial confirmed that the triple therapy combination of an anti-PD-1 antibody (Sintilimab), an HDAC inhibitor (Citarinostat), and an anti-VEGF antibody (Bevacizumab) demonstrated significant clinical efficacy in colorectal cancer
Both molecules are closely associated with aging biology
Many thyroid conditions, especially Hashimotos, are driven by chronic inflammation and an overactive immune response
PubMed: 35975308Clinical (RCT / meta-analysis) ref-3.Lizzo G, Migliavacca E, Lamers D, Frezal A, Corthesy J, Vinyes-Pares G, Bosco N, Karagounis LG, Hovelmann U, Heise T, von Eynatten M, Gut P A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage
Very large vials create tiny low-dose draws and may sit too long after mixing
It has been reported that the GSH concentration in many cancers including breast, ovarian, lung, as well as head and neck cancers is at least 4-fold higher than that in normal tissues 21,29,30
